Improved survival in ovarian cancer, with widening survival gaps of races and socioeconomic status: a period analysis, 1983-2012

Introduction: Ovarian cancer is the first leading cause of cancer-related deaths among gynecologic malignancies, and the 7th most common female cancer worldwide. However, previous studies on changes in the long-term survival of ovarian cancer were limited. Methods: Our data were extracted from Surveillance, Epidemiology, and End Results (SEER) registries to assess the incidence and relative survival changes of patients with ovarian cancer during 1983-2012. Patients with ovarian cancer were stratified by age, race, and socioeconomic status (SES). Cox regression analysis and Spearman rank correlation analysis were performed by STATA 12 software. Results: The overall incidence of ovarian cancer per 100,000 decreased from 13.7 to 12.4 to 10.8 over three decades with peak incidence occurring in the 70+ age group at 47.6, 45.7 and 40.2 in each respective decade. Median survival improved from 34 months to 46 months to 52 months over three decades, with the 5-year relative survival rate (RSR) increasing from 39.3% to 43.4% to 45.4% (p < 0.0001). However, Whites showed higher median survival (34 months) than Blacks (27 months) in the first decade, and the survival difference significantly increased to 16 months in the third decade. Additionally, the median survival difference between the low-poverty group and high poverty group increased from 4 months to 12 months in the three decades. Discussion: This study demonstrated the decreasing incidence of ovarian cancer with an observed improvement in relative survival over three decades in a large sample. However, the survival gaps among races and SESs significantly widened over the three decades.

[1]  T. Akinyemiju,et al.  Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites , 2017, Journal of Ovarian Research.

[2]  Samuel D. Towne Socioeconomic, Geospatial, and Geopolitical Disparities in Access to Health Care in the US 2011–2015 , 2017, International journal of environmental research and public health.

[3]  K. Matsuo,et al.  Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer , 2016, Obstetrics and gynecology.

[4]  S. Vitale,et al.  Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis , 2016, Archives of Gynecology and Obstetrics.

[5]  A. Whittemore,et al.  The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. , 2016, Cancer epidemiology.

[6]  N. Bickell,et al.  Ovarian Cancer Treatment and Survival Trends Among Women Older Than 65 Years of Age in the United States, 1995–2008 , 2016, Obstetrics and gynecology.

[7]  A. Sauaia,et al.  Primary Care Providers Perceptions of Racial/Ethnic and Socioeconomic Disparities in Hypertension Control. , 2015, American journal of hypertension.

[8]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[9]  Hongliu Sun,et al.  Survival improvement in patients with pancreatic cancer by decade: A period analysis of the SEER database, 1981–2010 , 2014, Scientific Reports.

[10]  Jason D. Wright,et al.  Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer. , 2014, Gynecologic oncology.

[11]  E. Chapman-Davis,et al.  Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. , 2014, Gynecologic oncology.

[12]  T. Jobo,et al.  Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial. , 2013, The Lancet. Oncology.

[13]  Bernd Holleczek,et al.  Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[14]  M. Doherty,et al.  Prognostic impact of marital status on survival of women with epithelial ovarian cancer , 2013, Psycho-oncology.

[15]  J. Tracy,et al.  Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. , 2012, Gynecologic oncology.

[16]  K. Frederiksen,et al.  Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study , 2009, BMJ : British Medical Journal.

[17]  R. Burger,et al.  Use of a dummy (pacifier) during sleep and risk of sudden infant death syndrome (SIDS): population based case-control study , 2005, BMJ : British Medical Journal.

[18]  J. Barnholtz-Sloan,et al.  Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. , 2003, American journal of obstetrics and gynecology.

[19]  S V Subramanian,et al.  Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures--the public health disparities geocoding project. , 2003, American journal of public health.

[20]  E. Trimble,et al.  Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Jarvis T. Chen,et al.  Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. , 2002, American journal of epidemiology.

[22]  J. Berek,et al.  Ovarian cancer: epidemiology, biology, and prognostic factors. , 2000, Seminars in surgical oncology.

[23]  E. Partridge,et al.  Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer , 1996, The New England journal of medicine.

[24]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[25]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[26]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[27]  P Maisonneuve,et al.  Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[28]  C. Griffiths Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975, National Cancer Institute monograph.